Clinical need for ototopical fluoroquinolones out-weighs miniscule risk of antibiotic resistance

Couzos, Sophie, and Councillor, Henry (2006) Clinical need for ototopical fluoroquinolones out-weighs miniscule risk of antibiotic resistance. Journal of Paediatrics and Child Health, 42 (4). pp. 223-224.

[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

View at Publisher Website:


[Extract] The National Aboriginal Community Controlled Health Organisation (NACCHO), in a double-blind randomized controlled trial, showed that the use of topical ciprofloxacin to treat chronic suppurative otitis media (CSOM) among 111 Aboriginal children improved the odds of clinical cure three fold compared with the current standard of topical aminoglycoside. Treatment did not lead to resistant isolates when followed up for 21 days, even among those with persistent discharge.1 Given the demonstrated efficacy and concerns about ototoxicity of aminoglycosides, it was recommended that ototopical ciprofloxacin be used as first-line treatment (in conjunction with ear toilet) for CSOM. Dr Coates correctly concludes in his review article that the theoretical concerns of resistance emerging from ototopical fluoroquinolones in this setting were considerably outweighed by the risk of bacterial resistance emerging from oral use.

Item ID: 31894
Item Type: Article (Other)
ISSN: 1440-1754
Additional Information:

Letter to the editor.

Date Deposited: 17 Mar 2014 05:10
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111717 Primary Health Care @ 100%
SEO Codes: 92 HEALTH > 9203 Indigenous Health > 920303 Aboriginal and Torres Strait Islander Health - Health System Performance (incl. Effectiveness of Interventions) @ 100%
Downloads: Total: 5
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page